Digital Therapeutics Market – Key Analysis & Vendor Profiles Report


Global digital therapeutics market is projected to reach USD 13.1 billion by 2026, at a CAGR of 31.4% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

Download PDF Brochure @

Market Segmentation & Coverage:

This research report categorizes the DIGITAL THERAPEUTICS to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the B2C sales channel market is further segmented into patients and caregivers. The caregivers segment dominated the market and is expected to register the highest CAGR of 17.2% during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). This is attributed to growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products

Based on Region, The digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW. The market in North America is expected to grow at the highest CAGR.

Request for Sample Pages @

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

Key Market Players:

Omada Health (US), WellDoc (US), Pear Therapeutics (US), Better Therapeutics (US), Happify (US), Proteus Digital Health (US), Propeller Health (US), Noom (US), Livongo Health (US), Akili Interactive Labs (US), Kaia Health (Germany)

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.


Drivers: Increasing incidence of preventable chronic diseases

Restraints: Patient data privacy concerns

Opportunities: Emerging markets

Challenges: Reluctance among patients to adopt digital therapeutics

The report provides insights on the following pointers:

  1. Market Penetration: Provides comprehensive information on the market offered by the key players
  2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Get 10% Discount on the first purchase of this report @


Comments are closed